Skip to main content
Livermore
Livermore
ZHEN

Wedbush Securities Inc

SEC CIK
0001142495
Latest filing
Jul 28, 2026

GSK holding history

GSK plc in every 13F filed by Wedbush Securities Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
5,982
Value
$314.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of GSK by Wedbush Securities Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,982$314.0K<0.1%−1,336−18.3%ReducedHolders
Q1 20267,318$404.0K<0.1%−421−5.4%ReducedHolders
Q4 20257,739$380.0K<0.1%+572+8.0%AddedHolders
Q3 20257,167$309.0K<0.1%+1,046+17.1%AddedHolders
Q2 20256,121$235.0K<0.1%+696+12.8%AddedHolders
Q1 20255,425$210.0K<0.1%+5,425NewHolders
Q3 20240$00.0%−10,541−100.0%Sold outHolders
Q2 202410,541$406.0K<0.1%−1,627−13.4%ReducedHolders
Q1 202412,168$522.0K<0.1%−7,406−37.8%ReducedHolders
Q4 202319,574$725.0K<0.1%−60.0%ReducedHolders
Q3 202319,580$710.0K<0.1%−1,368−6.5%ReducedHolders
Q2 202320,948$747.0K<0.1%−413−1.9%ReducedHolders
Q1 202321,361$760.0K<0.1%+20+0.1%AddedHolders
Q4 202221,341$750.0K<0.1%−2,558−10.7%ReducedHolders
Q3 202223,899$703.0K<0.1%+9,951+71.3%AddedHolders
Q2 202213,948$607.0K<0.1%−878−5.9%ReducedHolders
Q1 202214,826$646.0K<0.1%−544−3.5%ReducedHolders
Q4 202115,370$678.0K<0.1%+222+1.5%AddedHolders
Q3 202115,148$579.0K<0.1%−11,922−44.0%ReducedHolders
Q2 202127,070$1.08M0.1%+3,419+14.5%AddedHolders
Q1 202123,651$844.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.